Angiogenesis

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Angiogenesis is a journal published by Springer Science+Business Media in Netherlands. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,890 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
0969-6970 · 1573-7209
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
4,890 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2001-01-01
Indexing
MEDLINE
APC
4,890 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
139 days received→accepted — computed from PubMed (n=94)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1491

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

123

i10-index

1011

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
95%
ORCID iDs in current deposits
25%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Angiogenesis (DordrechtAngiogenesis (Boston
Source type
journal
NLM unique ID (PubMed)
9814575
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Angiogenesis and VEGF in Cancer
  • Angiogenesis and VEGF in Cancer
  • Angiogenesis and VEGF in Cancer
  • Lymphatic System and Diseases
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Cell Adhesion Molecules Research
  • Cell Adhesion Molecules Research
Show all subjects (75)
  • Cell Adhesion Molecules Research
  • Barrier Structure and Function Studies
  • Lymphatic System and Diseases
  • Lymphatic System and Diseases
  • Retinal Diseases and Treatments
  • Developmental Biology and Gene Regulation
  • Vascular Malformations and Hemangiomas
  • Protease and Inhibitor Mechanisms
  • Protease and Inhibitor Mechanisms
  • Axon Guidance and Neuronal Signaling
  • Axon Guidance and Neuronal Signaling
  • Cancer Cells and Metastasis
  • Retinal Diseases and Treatments
  • Retinal Diseases and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Nitric Oxide and Endothelin Effects
  • Vascular Tumors and Angiosarcomas
  • TGF-β signaling in diseases
  • Zebrafish Biomedical Research Applications
  • Zebrafish Biomedical Research Applications
  • Congenital heart defects research
  • Vascular Anomalies and Treatments
  • Mesenchymal stem cell research
  • Congenital heart defects research
  • Fibroblast Growth Factor Research
  • Vascular Malformations and Hemangiomas
  • Vascular Malformations and Hemangiomas
  • Wound Healing and Treatments
  • Axon Guidance and Neuronal Signaling
  • Protease and Inhibitor Mechanisms
  • Hippo pathway signaling and YAP/TAZ
  • Hippo pathway signaling and YAP/TAZ
  • Cellular Mechanics and Interactions
  • Tissue Engineering and Regenerative Medicine
  • Vascular Anomalies and Treatments
  • Vascular Malformations Diagnosis and Treatment
  • Vascular Anomalies and Treatments
  • Vascular Malformations Diagnosis and Treatment
  • Blood Coagulation and Thrombosis Mechanisms
  • Blood Coagulation and Thrombosis Mechanisms
  • Lymphatic Disorders and Treatments
  • TGF-β signaling in diseases
  • TGF-β signaling in diseases
  • Proteoglycans and glycosaminoglycans research
  • Nitric Oxide and Endothelin Effects
  • Nitric Oxide and Endothelin Effects
  • Proteoglycans and glycosaminoglycans research
  • Mesenchymal stem cell research
  • Kruppel-like factors research
  • Mesenchymal stem cell research
  • Kruppel-like factors research
  • Fibroblast Growth Factor Research
  • Fibroblast Growth Factor Research
  • Monoclonal and Polyclonal Antibodies Research
  • Zebrafish Biomedical Research Applications
  • Synthesis and biological activity
  • Retinal Development and Disorders
  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments
  • Immune cells in cancer
  • Cancer Cells and Metastasis
  • Immune cells in cancer
  • Cancer Cells and Metastasis
  • 3D Printing in Biomedical Research
  • Inflammatory mediators and NSAID effects
  • Inflammatory mediators and NSAID effects
  • 3D Printing in Biomedical Research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: